SCHEMBL7860296

SCHEMBL7860296

O=C1OC(c2ccccc2)C2CC3(CCN12)OCCO3

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.40
ALDH1A1 P00352 7/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CDK5 Q00535 1/20 0.36
DYRK1A Q13627 1/20 0.36
CDK5R1 Q15078 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
TSHR P16473 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
SIGMAR1 Q99720 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15358943 0.88 RAB9A (0.39) POLBALDH1A1NPC1RAB9AKMT2A
SCHEMBL15358974 0.81 CDK5 (0.43) POLBALDH1A1DDB1CRBNSMN1; SMN2
SCHEMBL15358949 0.76 NPC1 (0.44) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL11131918 0.73 SMN1; SMN2 (0.47) ALDH1A1DDB1CRBNSMN1; SMN2KMT2A
SCHEMBL11131933 0.73 SMN1; SMN2 (0.47) ALDH1A1DDB1CRBNSMN1; SMN2KMT2A
SCHEMBL11131926 0.73 SMN1; SMN2 (0.47) ALDH1A1DDB1CRBNSMN1; SMN2KMT2A
SCHEMBL23572358 0.72 DDB1 (0.40) ALDH1A1DDB1CRBNHSD17B10KDM4E
SCHEMBL13403264 0.72 SMN1; SMN2 (0.46) ALDH1A1DDB1CRBNSMN1; SMN2KMT2A
SCHEMBL3073967 0.69 DDB1 (0.36) ALDH1A1DDB1CRBNSMN1; SMN2GAA
SCHEMBL3073965 0.69 DDB1 (0.36) ALDH1A1DDB1CRBNSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551804-B1 SUBSTITUTED 1,4-DI-PIPERIDIN-4-YL-PIPERAZINE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2008-12-24 EP disclosed
US-7410970-B2 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists JANSSEN PHARMACEUTICA, N.V. (BE) 2008-08-12 US disclosed
US-7410970-B2 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists JANSSEN PHARMACEUTICA, N.V. (BE) 2008-08-12 US disclosed
EP-0869955-B1 N-ACYL-2-SUBSTITUTED-4-(BENZIMIDAZOLYL- OR IMIDAZOPYRIDINYL-SUBSTITUTED RESIDUES)-PIPERIDINES AS TACHYKININ ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2001-10-24 EP disclosed
US-6110939-A AS A SUBSTANCE P ANTAGONISTS TREATING TACHYKININ-MEDIATED DISEASE, ASTHMA, CENTRAL NERVOUS SYSTEM DISORDER JANSSEN PHARMACEUTICA N.V. (BE) 2000-08-29 US disclosed